CClinicalTrials.gg
CompletedNCT03641482Updated Mar 27, 2019

NBF Gingival Gel Application After Impacted Lower Third Molar Surgery

An interventional study of NBF and Placebo in Alveolar Osteitis, sponsored by Universidad Complutense de Madrid. Completed. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-03-27.

Sponsored by Universidad Complutense de Madrid · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Background: Alveolar osteitis is one of the most frequent complications after lower third molar extraction, and is usually accompanied by inflammation, pain and poor wound healing. Several local interventions have been used to reduce these complications with limited effectiveness.

Purpose: To clinically evaluate the use of propolis extract, nanovitamin C and nanovitamin E gel for the prevention of surgical complications related to impacted lower third molar extraction.

Methods: A randomized, triple-blind, split-mouth, pilot study is being performed in patients needing bilateral lower third molar extraction with similar surgical difficulty. Surgical extractions are randomly being performed and NBF gingival gel (TG) or placebo (PBG) are randomly being applied inside postextraction sockets by a blinded surgeon. The patients are being instructed to apply it 3 times/day in the surgical wound for 7 days. One month later, the contralateral wisdom tooth is being extracted and the opposite gel is being applied. Alveolar osteitis (AO) is being diagnosed following Blum's criteria. Swelling is being assessed by measuring the facial perimeter. Wound healing is being evaluated with a semi-quantitative scale as good, satisfactory or insufficient. Postoperative pain is being recorded using a visual analog scale (VAS) for 7 days. Analgesic pill intake is being recorded by each patient. Variables are being registered by a blinded researcher to 3M extractions at one, two, three and seven postoperative days.

02

Conditions studied

  • Alveolar Osteitis

Browse trials for

Keywords

  • third molar surgery
  • oral surgery
  • propolis
  • NBF gingival gel
  • post-surgical complications
  • clinica trial
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

The inclusion criteria are:

  • cooperative adult patients able to fulfil the study protocol,
  • needing surgical extractions of both lower third molars,
  • with similar surgical difficulty according to Pederson scale.

Exclusion criteria

Exclusion Criteria:

The exclusion criteria are

  • refuse to participate in the study,
  • failure to attend 24, 48, and 72 hours, as well as, 7 days post-surgical appointment visits,
  • smokers,
  • systemic diseases as diabetes mellitus or being immunosuppressed,
  • patients who take local or systemic antibiotics less than 3 months ago, anti-inflammatory or anticoagulant medication in the previous 4 weeks,
  • patients who require antibiotic prophylaxis,
  • pregnant or breastfeeding women,
  • patients with chronic periodontitis in active phase or
  • with history of allergies to any of the components of local anaesthetics, antibiotics, AINEs, or NBF gingival gel.
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Care provider)
Enrollment
13 participants (actual)

Study arms

  • Active comparator
    NBF

    Propolis Extract, Ascorbic Acid, Tocopherol Acetate, Sodium-Monofluorophosphate, Silicon Dioxide, Glycerin, D-sorbitol, Polyethyleneglycol 150, Sodium Carboxymethylcellulose, Xylitol, Sterol Glycoside, Peppermint Oil, L-Menthol, Methyl Hydroxybenzoate and Deionized Water

    Drug: NBF

  • Placebo comparator
    Placebo

    Sodium-Monofluorophosphate, Silicon Dioxide, Glycerin, D-sorbitol, Polyethyleneglycol 150, Sodium Carboxymethylcellulose, Xylitol, Sterol Glycoside, Peppermint Oil, L-Menthol, Methyl Hydroxybenzoate and Deionized Water

    Device: Placebo

Interventions

  • DrugNBF

    Once the molar is extracted, the socket is cleaned with water, NBF gel is introduced, and the flap is closed. Then, the patients are instructed to apply NBF Gel in the surgical wound 3 times per day for 7 days after brushing their teeth. Previously they have to dry the area of the wound with gauze.

  • DevicePlacebo

    Once the molar is extracted, the socket is cleaned with water, placebo gel is introduced, and the flap is closed. Then, the patients are instructed to apply placebo gel in the surgical wound 3 times per day for 7 days after brushing their teeth. Previously they have to dry the area of the wound with gauze.

05

What researchers measure

Primary outcomes

  1. Alveolar Osteitis: intense neuralgic pain in the post-extraction socket in the second or third postoperative day that do not disappear with analgesics beside a partially or totally disintegrated clot

    yes or no

    Time frame: from baseline to 24, 48, 72 hours post intervention

Secondary outcomes

  1. Swelling: it was evaluated with a flexible metric tape measuring the facial perimeter from trago to pogonion. A first measurement was made before surgery, which was compared with the measurements taken at 24, 48 and 72 hours of the extraction.

    changes

    Time frame: from baseline to 24, 48, 72 hours and 7 days post intervention

  2. Trismus: it was assessed measuring the maximum opening from the inter incisive points.

    changes

    Time frame: from baseline to 24, 48, 72 hours and 7 days post intervention

  3. Wound healing: it was assessed with a semi-quantitative scale (good, satisfactory or insufficient).

    changes

    Time frame: from baseline to 1 week post intervention

  4. Post extraction pain: it was recorded using a visual analog scale, ranging from 0 (no pain) to 10 (the worst pain imaginable) at 9 pm of 7 consecutive days.

    changes

    Time frame: from baseline to 1 week post intervention

  5. Number of rescue analgesic pills consumption: recorded for the first 3 days by the patients.

    number

    Time frame: from baseline to 3 days post intervention

06

Study locations

No study locations are listed for this record.

07

References and documents

Publications

  • Blum IR. Contemporary views on dry socket (alveolar osteitis): a clinical appraisal of standardization, aetiopathogenesis and management: a critical review. Int J Oral Maxillofac Surg. 2002 Jun;31(3):309-17. doi: 10.1054/ijom.2002.0263. PubMed 12190139 ↗
  • Haraji A, Rakhshan V, Khamverdi N, Alishahi HK. Effects of intra-alveolar placement of 0.2% chlorhexidine bioadhesive gel on dry socket incidence and postsurgical pain: a double-blind split-mouth randomized controlled clinical trial. J Orofac Pain. 2013 Summer;27(3):256-62. doi: 10.11607/jop.1142. PubMed 23882458 ↗
  • Madrazo-Jimenez M, Rodriguez-Caballero A, Serrera-Figallo MA, Garrido-Serrano R, Gutierrez-Corrales A, Gutierrez-Perez JL, Torres-Lagares D. The effects of a topical gel containing chitosan, 0,2% chlorhexidine, allantoin and despanthenol on the wound healing process subsequent to impacted lower third molar extraction. Med Oral Patol Oral Cir Bucal. 2016 Nov 1;21(6):e696-e702. doi: 10.4317/medoral.21281. PubMed 27475700 ↗
08

Registry details

Key details

Study ID
NCT03641482
Lead sponsor
Universidad Complutense de Madrid
Collaborators
Bio Nature Essences S.L
Responsible party
Rosa María López-Pintor Muñoz (Associate professor, Universidad Complutense de Madrid) — Principal investigator
First posted
Aug 22, 2018
Start date
Sep 1, 2016
Primary completion
Jul 15, 2017
Completion
Feb 20, 2018
Last update
Mar 27, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion